|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
19 February 2015 |
|
Main ID: |
NCT00604318 |
|
Date of registration:
|
17/01/2008 |
|
Prospective Registration:
|
Yes |
|
Primary sponsor: |
|
|
Public title:
|
Quality of Life, Recombinant TSH (Thyrogen) and Thyroid Cancer
|
|
Scientific title:
|
Is it Possible to Increase Quality of Life, Using Recombinant TSH Instead of Withdrawal of Thyroid Hormone Treatment, Before Iodine Uptake in Patients With Thyroid Cancer? |
|
Date of first enrolment:
|
February 2008 |
|
Target sample size:
|
56 |
|
Recruitment status: |
Completed |
|
URL:
|
http://clinicaltrials.gov/show/NCT00604318 |
|
Study type:
|
Interventional |
|
Study design:
|
Allocation: Randomized, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Caregiver), Primary Purpose: Treatment
|
|
Phase:
|
Phase 4
|
|
|
Countries of recruitment
|
|
Denmark
| | | | | | | |
|
Contacts
|
|
Name:
|
Birte Nygaard, Md, PhD |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
dept of endocrinology,Herlev Hospital |
| | |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- Follicular or papillary thyroid cancer
Exclusion Criteria:
- < 18 or > 75 years old
- Pregnant or lactating women
Age minimum:
18 Years
Age maximum:
75 Years
Gender:
Both
|
|
Health Condition(s) or Problem(s) studied
|
|
Thyroid Cancer
|
|
Intervention(s)
|
|
Drug: rhTSH
|
|
Primary Outcome(s)
|
|
quality of life
[Time Frame: month]
|
|
Secondary ID(s)
|
|
HB-2007-043
|
|
Dathyrca 1
|
|
2007-002713-39
|
|
Data register 2007-41-120
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|